Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: A glimmer of hope

European Journal of Internal Medicine

Volumn 20, Issue 5, 2009, Pages 490-493

  Ismail, Amani M ^a   Ziada, Hala N ^a   Sheashaa, Hussein A ^a   Shehab El Din, Ahmed B ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Blood donors; Egypt; Viral hepatitis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DETERIORATION; DISEASE COURSE; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTORY OF MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RURAL AREA; SCREENING; SEROPREVALENCE; SERUM; TREND STUDY; VIRUS HEPATITIS;

ADULT; BLOOD DONORS; COMMUNICABLE DISEASE CONTROL; CROSS-SECTIONAL STUDIES; EGYPT; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; YOUNG ADULT;

EID: 68949167289     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.03.005     Document Type: Article

References (27)

1. Cohen J. The scientific challenge of hepatitis C. Science 285 5424 (1999) 26-30
2. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 1 (2001) 41-52
3. Donato F., Boffetta P., and Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75 (1998) 347-354
4. Strickland G.T. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 43 5 (2006) 915-922
5. Frank C., Mohamed M.K., Strickland G.T., Lavanchy D., Arthur R.R., Magder L.S., et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355 9207 (2000) 887-891
6. Abdel-Aziz F., Habib M., Mohamed M.K., et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 32 1 (2000) 111-115
7. Nafeh M.A., Medhat A., Shehata M., Mikhail N.N., Swifee Y., Abdel-Hamid M., et al. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 63 5-6 (2000) 236-241
8. Arthur R.R., Hassan N.F., Abdallah M.Y., el-Sharkawy M.S., Saad M.D., Hackbart B.G., et al. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 91 (1997) 271-274
9. Abdul Mujeeb S., Nanan D., Sabir S., Altaf A., and Kadir M. Hepatitis B and C infection in first-time blood donors in Karachi-a possible subgroup for sentinel surveillance. East Mediterr Health J 12 6 (2006) 735-741
10. Deuffic-Burban S., Mohamed M.K., Larouze B., Carrat F., and Valleron A.J. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 44 3 (2006) 455-461
11. Palitzsch K.D., Hottentrager B., Schlottmann K., et al. Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol 11 (1999) 1215-1220
12. Zou S., Tepper M., and El Saadany S. Prediction of hepatitis C burden in Canada. Can J Gastroenterol 14 (2000) 575-580
13. Desenclos J.C. Epidemiology of hepatitis C. Revue du Praticien 50 (2000) 1066-1070
14. Law M.G., Dore G.J., Bath N., et al. Modelling hepatitis C virus incidence, prevalence, and long-term sequelae in Australia, 2001. Int J Epidemiol 32 (2003) 717-724
15. Alter M.J., Kruszon-Moran D., Nainan O.V., McQuillan G.M., Gao F., Moyer L.A., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341 (1999) 556-562
16. Puro V., Petrosillo N., Ippolito G., Aloisi M.S., Boumis E., and Rava L. Occupational hepatitis C virus infection in Italian health care workers. Am J Public Health 85 (1995) 1272-1275
17. Ansaldi F., Bruzzone B., Salmaso S., Rota M.C., Durando P., Gasparini R., et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76 3 (Jul 2005) 327-332
18. Raza S.A., Clifford G.M., and Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 96 7 (Apr 10 2007) 1127-1134
19. Tanaka J., Mizui M., Nagakami H., Katayama K., Tabuchi A., Komiya Y., et al. Incidence rates of hepatitis B and C virus infections among blood donors in Hiroshima, Japan, during 10 years from 1994 to 2004. Intervirology 51 1 (Feb 29 2008) 33-41
20. Mohamed M.K. Epidemiology of HCV in Egypt 2004. Afro-Arab Liver J 3 2 (2004) 41-52
21. Mohamed M.K., Hussein M.H., Massoud A.A., Rakhaa M.M., Shoeir S., Aoun A.A., and Aboul Naser M. Study of the risk factors for viral hepatitis C infection among Egyptians applying for work abroad. J Egypt Public Health Assoc 71 1-2 (1996) 113-147
22. Farghaly A.G., Mansour G.A., Mahdy N.H., and Yousri A. Hepatitis B and C virus infections among patients with gingivitis and adult periodontitis: seroprevalence and public health importance. J Egypt Public Health Assoc 73 5-6 (1998) 707-735
23. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5 (2005) 558-567
24. Abdel-Hamid M., El-Daly M., El-Kafrawy S., Mikhail N., Strickland G.T., and Fix A.D. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J Clin Microbiol 40 5 (2002) 1656-1659
25. Hutin Y., Hauri A., Chiarello L., et al. Best infection control practices for intradermal, subcutaneous, and intramuscular injections. Bull World Health Organ 81 (2003) 491-500
26. Bhavesh B., Shah M.D., and Wong J.B. The economics of hepatitis C virus. Clin Liver Dis 10 (2006) 717-734
27. Talaat M., Kandeel A., Rasslan O., Hajjeh R., Hallaj Z., El-Sayed N., et al. Evolution of infection control in Egypt: achievements and challenges. Am J Infect Control 34 4 (2006) 193-200